Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Increasing Investments in R&D by Pharmaceutical and Biotechnology Companies
4.3.2 Rising Demand from Drug Discovery and Genomics
4.4 Market Restraints
4.4.1 High Initial Investment
4.5 Industry Value Chain Analysis
4.6 Industry Attractiveness - Porter’s Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Equipment
5.1.1 Automated Liquid Handlers
5.1.2 Automated Plate Handlers
5.1.3 Robotic Arms
5.1.4 Automated Storage and Retrieval Systems (ASRS)
5.1.5 Analyzers
5.2 By Software
5.2.1 Laboratory Information Management System (LIMS)
5.2.2 Laboratory Information System (LIS)
5.2.3 Chromatography Data System (CDS)
5.2.4 Electronic Lab Notebook (ELN)
5.2.5 Scientific Data Management System (SDMS)
5.3 By Application
5.3.1 Drug Discovery
5.3.2 Genomics
5.3.3 Proteomics
5.3.4 Protein Engineering
5.3.5 Bioanalysis
5.3.6 Analytical Chemistry
5.3.7 Clinical Diagnostics
5.3.8 Other Applications
5.4 By Geography
5.4.1 North America
5.4.2 Europe
5.4.3 Asia-Pacific
5.4.4 Rest of the World


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific Inc.
6.1.2 Danaher Corporation / Beckman Coulter
6.1.3 Hudson Robotics Inc.
6.1.4 Becton Dickinson & Co.
6.1.5 Synchron Lab Automation
6.1.6 Agilent Technologies Inc.
6.1.7 Siemens Healthineers AG
6.1.8 Tecan Group Ltd
6.1.9 PerkinElmer Inc.
6.1.10 Inpeco
6.1.11 Roche Holding AG
6.1.12 Abbott Laboratories
6.1.13 Sysmex


7 INVESTMENT ANALYSIS


8 MARKET OPPORTUNITIES AND FUTURE TRENDS